Results 151 to 160 of about 13,112 (166)
Some of the next articles are maybe not open access.

[Angiotensin-2 type 1 receptors (AT1R) and cancers].

Nephrologie & therapeutique, 2013
Recently, several meta-analysis suggested an increased risk of cancers linked to the use of antagonists of angiotensin-2 receptors or inhibitors of angiotensinogen converting enzyme. The results of epidemiological studies are conflicting. Meta-analysis as well as retrospective studies are not reliable and biased, since they have never been designed to ...
Dolley-Hitze, Thibault   +8 more
openaire   +2 more sources

AT1R Antibody Assessment

Transplantation, 2018
Anne Halpin   +6 more
openaire   +1 more source

Protective Effect of AT1R Antibodies in Patients With ESKD on Hemodialysis

Journal of the American Society of Nephrology, 2022
Maria Lourdes Gonzalez Suarez   +4 more
openaire   +1 more source

Beta‐arrestin 2 mediates cardiac hypertrophy induced by thyroid hormones via AT1R

Journal of Cellular Physiology, 2021
Caroline Antunes Lino   +2 more
exaly  

AT1R gene polymorphism in coronary heart disease

Minerva Medica
Wei, Wang   +5 more
openaire   +2 more sources

Preeclampsia and angiotensin converting enzyme (ACE) I/D and angiotensin II type-1 receptor (AT1R) A1166C polymorphisms: association with ACE I/D polymorphism

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, 2013
Zohreh Rahimi   +2 more
exaly  

Luminal ANG II is internalized as a complex with AT1R/AT2R heterodimers to target endoplasmic reticulum in LLC-PK1cells

American Journal of Physiology - Renal Physiology, 2017
Heather A Drummond   +2 more
exaly  

Home - About - Disclaimer - Privacy